First guidance on appropriate use of controversial Alzheimer’s drugJuly 28, 2021Alzheimer's & CognitionNeurology
Occipital nerve stimulation offers relief for patients with intractable chronic cluster headacheJuly 28, 2021NeurologyPain
Legalization of cannabis tied to drop in opioid-related ED visitsJuly 16, 2021Addiction MedicineMental HealthNeurology
Zero benefit of aducanumab for Alzheimer’s disease, expert panel rulesJuly 16, 2021Alzheimer's & CognitionGeriatricsNeurology
Record number of U.S. drug overdoses in 2020July 14, 2021Addiction MedicineOpioid Resource CenterMental HealthNeurology
Contentious Alzheimer’s drug likely to get national coverage plan, CMS saysJuly 14, 2021Alzheimer's & CognitionBusiness of MedicineNeurologyGeriatrics
Dance training ‘drastically’ reduces Parkinson’s progression, eases symptomsJuly 14, 2021NeurologyGeriatrics
FDA updates label for controversial Alzheimer’s drug aducanumab (Aduhelm)July 8, 2021Alzheimer's & CognitionNeurology
Chronic stress and genetics can raise the risk of Alzheimer’s diseaseJuly 7, 2021Alzheimer's & CognitionGeriatricsNeurology
Hearing loss tied to decline in physical functioningJuly 2, 2021GeriatricsMental HealthNeurologyMusculoskeletal DisordersPreventive CareAlzheimer's & CognitionDepression
FDA fast-tracks lecanemab for Alzheimer’s diseaseJune 25, 2021Alzheimer's & CognitionNeurologyGeriatrics
